More in-depth stratification analysis suggested that CA125 was also a good prognostic indicator in TNM stage I to II ICC patients; that is, preoperative serum CA125 level could predict the tumor relapse of early-stage ICC. This evidence concerns the gene MUC16 and intrahepatic cholangiocarcinoma.